These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9366026)

  • 1. Species differences for stereoselective hydrolysis of propranolol prodrugs in plasma and liver.
    Yoshigae Y; Imai T; Horita A; Otagiri M
    Chirality; 1997; 9(7):661-6. PubMed ID: 9366026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereoselective hydrolysis of O-isovaleryl propranolol and its influence on the clearance of propranolol after oral administration.
    Shameem M; Imai T; Yoshigae Y; Sparreboom A; Otagiri M
    J Pharm Sci; 1994 Dec; 83(12):1754-7. PubMed ID: 7891307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the ester moiety on stereoselective hydrolysis of several propranolol prodrugs in rat tissues.
    Takahashi K; Tamagawa S; Sakano H; Katagi T; Mizuno N
    Biol Pharm Bull; 1995 Oct; 18(10):1401-4. PubMed ID: 8593445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of esterases involved in the stereoselective hydrolysis of ester-type prodrugs of propranolol in rat liver and plasma.
    Yoshigae Y; Imai T; Taketani M; Otagiri M
    Chirality; 1999; 11(1):10-3. PubMed ID: 9914648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Species differences in stereoselective hydrolase activity in intestinal mucosa.
    Yoshigae Y; Imai T; Horita A; Matsukane H; Otagiri M
    Pharm Res; 1998 Apr; 15(4):626-31. PubMed ID: 9587961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, stereoselective enzymatic hydrolysis, and skin permeation of diastereomeric propranolol ester prodrugs.
    Udata C; Tirucherai G; Mitra AK
    J Pharm Sci; 1999 May; 88(5):544-50. PubMed ID: 10229647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-performance liquid chromatographic analysis of the sulfation of 4-hydroxypropranolol enantiomers by monkey liver cytosol.
    Narimatsu S; Kobayashi N; Asaoka K; Masubuchi Y; Horie T; Hosokawa M; Ishikawa T; Ohmori S; Kitada M; Miyano J; Kataoka H; Yamamoto S
    Chirality; 2001; 13(3):140-7. PubMed ID: 11270323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Species differences in the disposition of propranolol prodrugs derived from hydrolase activity in intestinal mucosa.
    Yoshigae Y; Imai T; Aso T; Otagiri M
    Life Sci; 1998; 62(14):1231-41. PubMed ID: 9570338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereoselective hydrolysis of O-acetyl propranolol as prodrug in rat tissue homogenates.
    Takahashi K; Tamagawa S; Haginaka J; Yasuda H; Katagi T; Mizuno N
    J Pharm Sci; 1992 Mar; 81(3):226-7. PubMed ID: 1640358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereoselective hydrolysis and penetration of propranolol prodrugs: in vitro evaluation using hairless mouse skin.
    Ahmed S; Imai T; Otagiri M
    J Pharm Sci; 1995 Jul; 84(7):877-83. PubMed ID: 7562441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for the involvement of a pulmonary first-pass effect via carboxylesterase in the disposition of a propranolol ester derivative after intravenous administration.
    Imai T; Yoshigae Y; Hosokawa M; Chiba K; Otagiri M
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1234-42. PubMed ID: 14534358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereoselectivity in cutaneous hydrolysis and transdermal transport of propranolol prodrug.
    Ahmed S; Imai T; Otagiri M
    Enantiomer; 1997; 2(3-4):181-91. PubMed ID: 9676267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic, intestinal, renal, and plasma hydrolysis of prodrugs in human, cynomolgus monkey, dog, and rat: implications for in vitro-in vivo extrapolation of clearance of prodrugs.
    Nishimuta H; Houston JB; Galetin A
    Drug Metab Dispos; 2014 Sep; 42(9):1522-31. PubMed ID: 24994071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereoselective hydrolysis of xenobiotic esters by different cell lines from rat liver and hepatoma and its application to chiral prodrugs for designated growth suppression of cancer cells.
    Kageyama Y; Yamazaki Y; Afify AS; Ogawa Y; Okada T; Okuno H
    Chirality; 1995; 7(4):297-304. PubMed ID: 7640174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidation of (R)- and (S)-propranolol in human and dog liver microsomes. Species differences in stereoselectivity.
    von Bahr C; Hermansson J; Lind M
    J Pharmacol Exp Ther; 1982 Aug; 222(2):458-62. PubMed ID: 7097564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-dealkylation of propranolol in rat, dog, and man. Chemical and stereochemical aspects.
    Nelson WL; Bartels MJ
    Drug Metab Dispos; 1984; 12(3):345-52. PubMed ID: 6145562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of stereoselective transdermal transport and concurrent cutaneous hydrolysis of several ester prodrugs of propranolol: mechanism of stereoselective permeation.
    Ahmed S; Imai T; Otagiri M
    Pharm Res; 1996 Oct; 13(10):1524-9. PubMed ID: 8899845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereospecific chemical and enzymatic stability of phosphoramidate triester prodrugs of d4T in vitro.
    Siccardi D; Gumbleton M; Omidi Y; McGuigan C
    Eur J Pharm Sci; 2004 May; 22(1):25-31. PubMed ID: 15113580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereospecific activity and nature of metabolizing esterases for propranolol prodrug in hairless mouse skin, liver and plasma.
    Ahmed S; Imai T; Yoshigae Y; Otagiri M
    Life Sci; 1997; 61(19):1879-87. PubMed ID: 9364192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carboxylesterase in the liver and small intestine of experimental animals and human.
    Taketani M; Shii M; Ohura K; Ninomiya S; Imai T
    Life Sci; 2007 Aug; 81(11):924-32. PubMed ID: 17764701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.